ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea · Delayed Price · Currency is KRW

27,600

0.00 (0.00%)

At close: Sep 9, 2026

ROKIT Healthcare Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	32,814	26,247	13,111	12,418	9,151	6,741
Revenue Growth	106.19%	100.19%	5.59%	35.70%	35.76%	68.94%
Gross Profit	15,926	15,670	5,964	4,026	3,064	1,615
Operating Income	-15,393	35.58	-6,042	-7,568	-13,873	-17,320
Net Income	-12,690	-2,845	-7,646	16,600	1,875	-56,247
Earnings Per Share	-812.87	-222.00	-978.30	-829.59	-1232.84	-8218.00
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	14,678	7,360	9,973	6,804	5,023
Overseas	11,569	5,751	2,445	2,347	1,718
Total	26,247	13,111	12,418	9,151	6,741

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	63,158	32,079	4,601	2,489	4,877	4,750
Total Debt	25,522	26,152	14,729	11,432	9,129	8,840
Net Cash (Debt)	37,636	5,927	-10,128	-8,943	-4,252	-4,090
Net Cash Growth	461.12%	-	-	-	-	-
Net Cash Per Share	2410.17	461.84	-1295.97	-753.00	-360.30	-597.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-25,755	-17,230	-5,002	-3,916	-6,586	-11,823
Capital Expenditures	-427.41	-163.34	-20.45	-148.65	-191.13	-297.44
Free Cash Flow	-26,183	-17,393	-5,023	-4,065	-6,777	-12,121
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	48.54%	59.70%	45.49%	32.42%	33.49%	23.96%
Operating Margin	-46.91%	0.14%	-46.09%	-60.94%	-151.61%	-256.95%
Pretax Margin	-35.98%	-7.31%	-55.96%	135.54%	22.15%	-834.99%
Profit Margin	-38.67%	-10.84%	-58.31%	133.68%	20.48%	-834.44%
FCF Margin	-79.79%	-66.27%	-38.31%	-32.73%	-74.06%	-179.81%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	132.39	-	-	-	-
PS Ratio	14.61	38.97	-	-	-	-